About CHR Verviers
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Hoffmann-La Roche
4
AIO-Studien-gGmbH
1
AZ-VUB
1
Celgene
1
Galera Therapeutics, Inc.
1
Ipsen
1
Janssen Research & Development, LLC
1
Karyopharm Therapeutics Inc
1
UNICANCER
1
Universiteit Antwerpen
1
University Hospital, Antwerp
1
Clinical Trials at CHR Verviers
During the past decade, CHR Verviers conducted 11 clinical trials. In the 10-year time frame, 11 clinical trials started and 3 clinical trials were completed, i.e. on
average, 27.3% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 1 clinical trials were completed. i.e. 50%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Study of Subcutaneous Mircera for the Maintenance Treatment of Participants With Chronic Renal Anemia
2008-06-30
2009-12-31
Completed
35
Adjuvant Systemic Treatment for (ER)-Positive HER2-negative Breast Carcinoma in Women Over 70 According to Genomic Grade (GG): Chemotherapy + Endocrine Treatment Versus Endocrine Treatment
2012-04-12
2026-03-01
Active, not recruiting
1,989
A Study of Subcutaneous Versus Intravenous MabThera/Rituxan (Rituximab) in Combination With CHOP Chemotherapy in Patients With Previously Untreated CD20-Positive Diffuse Large B-Cell Lymphoma
2012-08-24
2016-09-16
Completed
572
BELOVA Data Collection: Safety and Efficacy of Frontline Bevacizumab Treatment in Participants With Ovarian Cancer 70 Years and Older
2015-04-23
2019-06-14
Completed
76
A Study to Assess the Impact of Sarcopenia on the Outcomes of Colorectal Cancer Patients Treated With Chemotherapy Combined With Bevacizumab
2016-03-14
2020-02-04
Completed
200
Tailored ImmunoTherapy Approach With Nivolumab in Subjects With Metastatic or Advanced Renal Cell Carcinoma
2016-10-01
2022-10-01
Completed
200
A Safety Study of Lenalidomide in Previously Untreated Adult Multiple Myeloma Patients Who Are Not Eligible for Transplant
2017-03-31
2026-01-13
Active, not recruiting
911
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "CHR Verviers" #1 sponsor was "Hoffmann-La Roche" with 4 trials, followed by "AIO-Studien-gGmbH" with 1 trials
sponsored, "AZ-VUB" with 1 trials sponsored, "Celgene" with 1 trials sponsored and "Galera Therapeutics, Inc."
with 1 trials sponsored. Other sponsors include 1 different institutions and
companies that sponsored additional 11 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "CHR Verviers"
#1 collaborator was "Anticancerfund" with 1 trials as a collaborator, "Belgium and Luxembourg Gynaecological Oncology Group" with 1 trials as a collaborator, "Bristol-Myers Squibb" with 1 trials as a collaborator, "Israel Society of Gynecologic Oncology" with 1 trials as a collaborator and "Kom Op Tegen Kanker" with 1 trials as a collaborator. Other collaborators include 3 different institutions and companies that were
collaborators in the rest 13 trials.
Clinical Trials Conditions at CHR Verviers
According to Clinical.Site data, the most researched conditions in "CHR Verviers" are
"Breast Cancer" (2 trials), "Advanced or Metastatic Renal Cell Carcinoma" (1 trials), "Anemia" (1 trials), "Carcinoma, Renal Cell" (1 trials) and "Chronic Kidney Diseases" (1 trials). Many other conditions were trialed in "CHR Verviers" in a lesser frequency.
Clinical Trials Intervention Types at CHR Verviers
Most popular intervention types in "CHR Verviers" are "Drug" (10 trials), "Other" (2 trials), "Biological" (1 trials) and "Radiation" (1 trials). Other intervention types were less common.
The name of intervention was led by "Paclitaxel" (2 trials), "Archival Tumor Tissue Sample" (1 trials), "Bevacizumab" (1 trials), "CHEMOTHERAPY then HORMONOTHERAPY" (1 trials) and "CHOP" (1 trials). Other intervention names were less common.
Clinical Trials Genders at CHR Verviers
The vast majority of trials in "CHR Verviers" are
10 trials for "All" genders and 4 trials for "Female" genders.
Clinical Trials Status at CHR Verviers
Currently, there are NaN active trials in "CHR Verviers".
undefined are not yet recruiting,
2 are recruiting,
3 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 8 completed trials in CHR Verviers,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in CHR Verviers, 0 "Phase 1"
clinical trials were conducted, 3 "Phase 2" clinical
trials and 5 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 1 trials, and there were
also 0 trials that are defined as “Not Applicable".